In last trading session, Acurx Pharmaceuticals Inc (NASDAQ:ACXP) saw 0.25 million shares changing hands with its beta currently measuring -1.88. Company’s recent per share price level of $1.14 trading at $0.0 or 0.44% at ring of the bell on the day assigns it a market valuation of $19.34M. That closing price of ACXP’s stock is at a discount of -363.16% from its 52-week high price of $5.28 and is indicating a premium of 12.28% from its 52-week low price of $1.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 74.74K if we extend that period to 3-months.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP) trade information
Upright in the green during last session for gaining 0.44%, in the last five days ACXP remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $1.14 price level, adding 22.45% to its value on the day. Acurx Pharmaceuticals Inc’s shares saw a change of -70.10% in year-to-date performance and have moved -17.63% in past 5-day. Acurx Pharmaceuticals Inc (NASDAQ:ACXP) showed a performance of -40.97% in past 30-days. Number of shares sold short was 0.47 million shares which calculate 12.59 days to cover the short interests.
Acurx Pharmaceuticals Inc (ACXP) estimates and forecasts
Statistics highlight that Acurx Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -54.38% of value to its shares in past 6 months, showing an annual growth rate of 22.61% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -17.77% during past 5 years.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s Major holders
Insiders are in possession of 14.80% of company’s total shares while institution are holding 11.96 percent of that, with stock having share float percentage of 14.04%. Investors also watch the number of corporate investors in a company very closely, which is 11.96% institutions for Acurx Pharmaceuticals Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at ACXP for having 0.49 million shares of worth $1.11 million. And as of 2024-06-30, it was holding 3.1778 of the company’s outstanding shares.
The second largest institutional holder is PROSPECT FINANCIAL SERVICES LLC, which was holding about 0.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.7974 of outstanding shares, having a total worth of $0.63 million.
